ACTRN12618000704291尚未招募未知
A 12-week, randomized, placebo-controlled, pilot trial of a novel nutritional formula developed as an adjunctive treatment for negative symptoms in first-episode psychosis
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 35 Years（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Clinical trial for the evaluation of the efficacy and safety of the extracts of lotus leaf complex on blood lipid levels.Endocrine, nutritional and metabolic diseaseKCT0003136Korea Inspharm68
进行中（未招募）
1 期
A 12-week, randomized, single-blind, placebo-controlled, multi-centre, parallel group, phase IIa study to evaluate efficacy, safety and tolerability of oral AZD5718 after 4- and 12-weeks of treatment in patients with coronary artery disease (CAD)Coronary artery diseaseEUCTR2017-001582-25-FIAstraZeneca AB200
进行中（未招募）
1 期
A 12-week, randomized, single-blind, placebo-controlled, multi-centre, parallel group, phase IIa study to evaluate efficacy, safety and tolerability of oral AZD5718 after 4- and 12-weeks of treatment in patients with coronary artery disease (CAD)EUCTR2017-001582-25-DKAstraZeneca AB200
招募中
不适用
Clinical Trial for the evaluation of the efficacy and safety of 7-MEGATM500 on the Skin wrinkle improvementDiseases of the skin and subcutaneous tissueKCT0004592Vitech90
已完成
不适用
A Clinical Trial for the evaluation of the efficacy and safety of RW0117 on dyspepsiaKCT0005265Richwood Trading Company, LTD.100